Qiagen
Pharmaceutical and research company with headquarters is in Germany.
Nasdaq or NYSE listed Biotechnology: Biological Products (No Diagnostic Substances) industry Top Companies List by Market Cap as of Jan-05-2024. Nasdaq and NYSE related Biotechnology: Biological Products (No Diagnostic Substances) industry Largest Companies List by Market Cap as of Jan-05-2024
Pharmaceutical and research company with headquarters is in Germany.
Exelixis is a Commercially successful and Oncology Focused Biotechnology company. The company established a broad drug discovery and development platform that has served as the foundation for continued efforts to bring new cancer therapies to patients in need. Headquarters is in USA.
Biotechnology company and gene editing company to control couple of human diseases like Cancer and couple of other diseases and it's headquarters is in Switzerland.
With CRISPR/Cas9, they aim to target the source of genetically-defined diseases and engineer the next generation of cellular therapies
Halozyme Therapeutics is a Biotechnology Company focused on novel biological and drug delivery approaches. It is having approximately 130 employees. The headquarters is in USA.
GINKGO BIOWORKS HOLDINGS, INC.is a Biotechnology Holding company, and its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Headquarters is in USA.
The company is a biotechnology company that manufactures biologic medicines like insulin to vaccines to monoclonal antibody cancer therapies, biologic medicines. Headquarters is in Iceland.
Immunocore is a pioneering, clinical-stage T cell receptor biotechnology company working to develop and commercialize a new generation of transformative medicines to address unmet needs in cancer, infection and autoimmune disease. Headquarters is in UK.